GTMB 7 - Gene Therapy & Molecular Biology

Gene Therapy and Molecular Biology Vol 7, page 147adenovirus vectors for infection of cardiovascular tissues. J.Virol. 75, 3335-3342.Havenga M, Lemckert A, Ophorst O, Meijer M, Germeraad W,Grimbergen J, Doel M, Vogels R, Duetekom, J, Janson A,Bruijn J, Uytdehaag F, Quax, P, Logtenberg T, Mehtali M,Bout A (2002) Exploiting the natural diversity in adenovirustropism for therapy and prevention of disease. Virology 76,4612 - 4620.Hedman M, Hartikainen J, Syvanne M, Stjernvall J, Hedman A,Kivela A, Vanninen E, Mussalo H, Kauppila E, S S,Narvanen O, Rantala A, Peuhkurinen K, Nieminen M,Laakso M, Yla-Herttuala S (2003) Safety and feasibility ofcatheter-based local intracoronary vascular endothelialgrowth factor gene transfer in the prevention ofpostangioplasty and in-stent restenosis and in the treatmentof chronic myocardial ischemai. Phase II results of theKupoio Angiogenesis Trial (KAT) Circulation 107, 2677-2683.Hiltunen M.O, Turunen M.P, Turunen A.-M, Rissanen TLaitinen M, Kosma V.-M, Yla-Herttuala S (2000)Biodistribution of adenoviral vector to nontarget tissues afterlocal in vivo gene transfer to arterial wall using intravascularand periadventitial gene delivery methods. FASEB Journal14, 2230-2236.Hu Y, Baker A, Zou Y, Newby, A, Xu Q (2001) Local genetransfer of tissue inhibitor of metalloproteinase-2 influencesvein graft remodeling in a mouse model. ArteriosclerThromb Vasc Biol 21, 1275-1280.Huang J, Frischer J, Serur A, Kadenhe A, Yokoi A, McCruddenK, New, T, O'Toole K, Zabski S, Rudge J, Holash, J,Yancopoulos G, Yamashiro D, Kandel J (2003) Regressionof established tumors and metastases by potent vascularendothelial growth factor blockade. Proc Natl Acad SciUSA 100, 7785-7790.Iaccarino G, Smithwick, L, Lefkowitz, R, Koch, W (1999)Targetting Gbeta gamma signaling in arterial vascularsmooth muscle proliferation: a novel strategy to limitrestenosis. Proc Natl Acad Sci USA 96, 3945-3950.Igarashi T, Miyake K, Kato K, Watanabe A, Ishizaki M, OharaK, Shimada T (2003) Lentivirus-mediated expression ofangiostatin efficiently inhibits neovascularization in a murineproliferative retinopathy model. Gene Ther 10, 219-226.Isner J, Pieczek, A, Schainfeld R, Blair R, Haley, L, Asahara T,Rosenfield K, Razvi S, Walsh, E, Symes J.F (1996) Clinicalevidence of angiogenesis after arterial gene transfer ofphVEGF (165) in patient with ischaemic limb. Lancet 348,370-374.Janssen S, Flaherty, D, Nong Z, Varenne O, Van Pelt N,Haustermans C, Zoldhelyi P, Gerard R, Collen D (1998)Human endothelial nitric oxide synthase gene transferinhibits vascular smooth muscle cell prolifeation andneointima formation after balloon injury in rats. Circulation97, 1274-1281.Jayakumar J, Suzuki K, Khan M, Smolenski R, Farrell A, LatifN, Raisky, O, Abunasra H, Sammut I, Murtuza B, AmraniM, Yacoub M (2000) Gene therapy for myocardialprotection: transfection of donor hearts with heat shockprotein 70 gene protects cardiac function against ischemiareperfusioninjury. Circulation 102 (19 suppl 3), III302-III306.Katovich, M, Gelband C, Reaves P (1999) Reversal ofhypertension by angiotensin II type 1 receptor antisense genetherapy in the adult SHR. Am J Physiol 277, H1260-H1264.Kibbe M.R, Tzeng E, Gleixner S, Watkins S, Kovesdi L,Lizonova A, Makaroun M, Billiar T, Rhee R (2001)Adenovirus-meidated gene transfer of human inducible nitricoxide synthase in porcine vein grafts inhibits intimalhyperplasia. J Vasc Surg 34, 156-165.Kimura B, Mohuczy, D, Tang X, Phillips I (2001) Attenuation ofhypertension and heart hypertrophy by adeno-associatedvirus delivering angiotensinogen antisense. Hypertension37, 376 - 380.Klugherz, B, Song C, Defelice S, Cui X, Lu Z, Connolly, J,Hinson J, Wilensky, R, Levy, R (2002) Gene delivery to pigcoronary arteries from stents carrying antibody-tetheredadenovirus. Human Gene Ther 13, 443 - 454.Klugherz, B.D, Jones P, Cui X, Chen W, Meneveau N.F,DeFelice S, Connolly J, Wilensky, R, Levy, R (2000) Genedelivery from a DNA controlled-release stent in porcinecoronary arteries. Nat Biotechnol 18 (11), 1181-4.Kochanek, S, Clemens P.R, Mitani K, Chen H.-H, Chan S,Caskey, C. (1996) A new adenoviral vector: replacement ofall viral coding sequences with 28kb of DNA independentlyexpressing both full-length dystrophin and B-galactosidase.Proc Natl Acad Sci USA 93, 5731-5736.Koike H, Morishita R, Iguchi S, Aoki M, Matsumoto K,Nakamura T, Yokoyama C, Tanabe T, Ogihara T, Kaneda Y(2003) Enhanced angiogenesis and improvement ofneuropathy by cotransfection of human hepatocyte growthfactor and prostacyclin synthase gene. FASEB Journal 17,779-781.Laitinen M, Hartikainen J, Hiltunen M.O, Eranen J, KiviniemiM, Narvanen O, Makinen K, Manninen H, Syvanne M,Martin J.F, Laakso M, Yla-Herttuala S (2000) Cathetermediatedvascular endothelial growth factor gene transfer tohuman coronary arteries after angioplasty. Human GeneTher 11, 263-270.Lamfers M, Lardenoye J, de Vries M.R, Aalders M, EngelseMA, Grimbergen J, van Hinsbergh, V, Quax, P (2001) Invivo suppression of restenosis in balloon-injured rat carotidartery by adenovirus-mediated gene transfer of the cellsurface-directed plasmin inhibitor ATF.BPTI. Gene Ther 8,534-541.Lawrie A, Brisken A, Francis S, Tayler D, Chamberlain J,Crossman D, Cumberland D, Newman C (1999) UltrasoundEnhances Reporter Gene Expression After Transfection ofVascular Cells In Vitro. Circulation 99, 2617-2620.Lee R, Springer M, Blanco-Bose W.E, Shaw, R, Ursell P Blau H(2000) VEGF Gene Delivery to Myocardium: DeleteriousEffects of Unregulated Expression. Circulation 102, 898-901.Lemarchand P, Jones M, Yamada I, Crystal R (1993) In vivogene transfer and expression in normal uninjured bloodvessels using replication-deficient recombinant adenovirusvectors. Circ Res 72, 1132-1138.Li JM, Brooks G (1999) Cell cycle regulatory molecules (cyclinscyclin-dependent kinases and cyclin dependent kinaseinhibitors) and the cardiovascular system. Potential targetsfor therapy? Eur Heart J 20, 406-420.Li Q, Bolli R, Qiu Y, Tang X, Guo Y, French, B (2001) Genetherapy with extracellular superoxide sismutase protectsconscious rabbits against myocardial infarction. Circulation103, 1893-1898.Lin K.F, Chao J, Chao L (1995) Human atrial natriuretic peptidegene delivery reduces blood pressure in hypertensive rats.Hypertension 26, 847-853.Lin K.F, Chao L, Chao J (1997) Prolonged reduction of highblood pressure with human nitric oxide synthase genedelivery. Hypertension 30, 307-313.147